In fact, CCR5, along with other chemokine receptors [18–27] have also been recognized as key participants in neurodegenerative diseases such as Alzheimer’s disease and other neuroinflammatory entities. This evidence concerns the gene CCR5 and early-onset autosomal dominant Alzheimer disease.